Supplements

Supplements

This page covers supplements in the klatiWAY stack that don’t have their own dedicated deep-dive posts — taurine, TMG (betaine), and hyaluronic acid. It also covers blood donation as a health protocol. For creatine, glycine, vitamin D, and electrolytes — see their dedicated pages.

These supplements fill gaps that are hard to close with diet alone. None of them replaces food, sleep, or training. They’re included in the protocol because the evidence supports a meaningful benefit-to-cost ratio.

This page is a living document. It will be updated every time a new supplement is deeply researched, tested, and added to the klatiPRO protocol.

---

L-Taurine

Taurine is the most abundant free amino acid in your heart, brain, retina, and muscle — but it’s not used to build proteins. It works as a cellular protector: stabilizing membranes, scavenging oxidative damage, supporting mitochondrial energy production (ATP synthesis), and modulating neurotransmission.

Your body makes taurine from cysteine (requires vitamin B6), but production declines sharply with age. A landmark 2023 multi-species study found that taurine levels drop roughly 80% between age 25 and 65 — and that this decline is associated with aging across species.

Why taurine

• Cardiovascular protection — associated with lower blood pressure, improved endothelial function, and reduced cardiovascular risk markers (surrogate endpoints — blood pressure and biomarkers, not hard cardiovascular events)
• Anti-inflammatory and antioxidant — associated with reduced oxidative stress markers (MDA) and inflammatory cytokines (TNF-α, IL-6) in dose-dependent fashion (surrogate markers)
• Mitochondrial function — required for taurine modification of mitochondrial tRNA, which is essential for proper ATP synthesis. Without it, mitochondria produce less energy
• Bile acid conjugation — taurine conjugates with bile acids (taurocholate), improving fat digestion and cholesterol metabolism
• Brain protection — acts on GABA (inhibitory neurotransmitter) receptors, regulates cell volume in the brain (osmoregulation), and provides neuroprotective effects
• Metabolic health — associated with improved insulin sensitivity and reduced metabolic syndrome risk in clinical trials
• Aging defense — a landmark 2023 multi-species study showed supplementation increased median lifespan 10–12% in mice and improved healthspan markers in monkeys

What the evidence shows

Blood pressure

A 2016 randomized controlled trial gave 120 prehypertensive adults 1.6g taurine daily for 12 weeks. Results: significant reduction in both systolic and diastolic blood pressure, plus improved endothelial function — meaning the blood vessels worked better, not just the pressure number.

Inflammation and oxidative stress

A 2022 dose-response meta-analysis of randomized controlled trials (RCTs) found that taurine supplementation significantly reduces MDA (a marker of oxidative damage) and TNF-α (a key inflammatory cytokine). The sweet spot was 1.5–3g/day for at least 8 weeks.

Metabolic syndrome

A 2024 meta-analysis of RCTs found taurine supplementation reduces metabolic syndrome risk — improved insulin sensitivity, lipid profiles, and glucose metabolism. A comprehensive 2025 meta-analysis confirmed these cardiometabolic benefits across multiple endpoints.

Aging

A landmark 2023 multi-species study found:

• Taurine levels decline ~80% from age 25 to 65 in humans
• Supplementation increased median lifespan 10–12% in mice
• Improved healthspan in monkeys — less weight gain, better bone density, lower fasting glucose
• Mechanism: reduced cellular senescence, protected telomeres, improved mitochondrial function, less DNA damage, reduced chronic inflammation

This is multi-species evidence — not a single human RCT on longevity. The human data is correlational. The mechanistic evidence is stronger than typical supplement studies, but longevity claims remain unproven in humans.

Exercise recovery

Taurine is associated with reduced muscle damage markers (CK, LDH) and less muscle soreness (DOMS — delayed onset muscle soreness) after exercise in trained individuals. Effects are most consistent with 2–3g daily for 7–14 days before training in active adults. Not a strong ergogenic aid on its own, but a meaningful recovery support.

Doses

• 1.5–3g/day — effective range for healthy adults, supported by cardiovascular, anti-inflammatory, and metabolic meta-analyses
• 2.5g/day — klatiWAY protocol dose — sits in the optimal range for most studied benefits
• Safe at doses up to 6g/day based on regulatory assessments. A systematic safety review found no adverse effects pattern at therapeutic doses
• No established upper limit

Dietary sources

• Animal foods — shellfish (~800mg/100g), dark poultry meat (~170mg/100g), fish (~40–70mg/100g), red meat (~40–50mg/100g)
• Omnivore diets provide roughly 40–400mg/day
• Vegetarian and vegan diets provide near zero — the body must rely entirely on endogenous synthesis, which slows with age
• Endogenous production requires cysteine and vitamin B6 — B6 deficiency reduces taurine synthesis

Side effects

• GI (gastrointestinal) tolerance — generally excellent; rare mild nausea or diarrhea at high doses (>3g)
• No known serious adverse effects at any studied dose in healthy adults (up to 6g/day)
• No established drug interactions in clinical literature — but consult a doctor if you’re on blood pressure (BP) medication, since taurine also lowers BP
• ⚠️ Energy drinks pair taurine with high caffeine and sugar — the problems come from those, not taurine

---

TMG (Betaine Anhydrous)

TMG — trimethylglycine, also called betaine anhydrous — is a methyl donor. Your liver uses it to recycle homocysteine back into methionine via the BHMT (betaine-homocysteine methyltransferase) pathway, which then produces SAM (S-adenosylmethionine), the body’s universal methyl donor. Methylation is required for DNA (deoxyribonucleic acid) repair, detoxification, neurotransmitter production, and creatine synthesis.

Why TMG

• Lowers homocysteine — elevated homocysteine is an independent cardiovascular risk marker; TMG reduces it reliably
• Supports methylation — provides methyl groups for the BHMT pathway, supporting SAM production
• Liver protection — protects against alcohol-induced and fat-induced liver damage through methyl donation and anti-inflammatory effects
• Strength performance — associated with improved lower-body strength and vertical jump in trained individuals (meta-analysis of 17 studies)
• Supports endogenous creatine synthesis — provides methyl groups used in the creatine synthesis pathway (but does not replace creatine supplementation)

What the evidence shows

Homocysteine reduction

A 2022 meta-analysis confirmed that betaine supplementation significantly reduces plasma homocysteine (weighted mean difference -1.30 μmol/L). A 2003 RCT showed that 6g/day betaine lowered homocysteine in healthy, sedentary adults — this effect does not require exercise. Methylation benefits work independently.

But is this clinically meaningful? A large prospective cohort (17,357 women, 6-year follow-up) found only a weak association between higher dietary betaine intake and reduced cardiovascular disease (CVD) risk. Homocysteine reduction is established — whether that reduction alone prevents cardiovascular events is still uncertain.

Exercise performance — strength, not endurance

A 2024 meta-analysis of 17 studies (317 participants) found:

• Significant improvement in maximal strength (effect size 0.47), particularly lower body
• Vertical jump improved (effect size 0.36)
• No effect on upper-body strength or muscular endurance
• Benefits appear after ≥7 days of supplementation

Important: A 2012 RCT directly compared betaine vs creatine in trained men — creatine increased muscle phosphocreatine and strength, betaine did not. TMG does not replace creatine for muscle energy. Its strength benefits likely come from the methylation pathway, not from direct energy storage.

A separate 2022 meta-analysis found betaine supplementation does not improve body composition in healthy adults — no effect on body mass, BMI (body mass index), or body fat percentage.

Liver protection

Evidence supports betaine’s protective effect against alcohol-induced liver damage through methyl donation and anti-inflammatory mechanisms. A 2009 RCT used 20g/day for 1 year in NASH (non-alcoholic steatohepatitis) patients — failure to improve liver outcomes at that dose, but also no serious adverse effects, confirming safety even at extreme doses.

For non-alcoholic fatty liver disease (NAFLD), pilot trials are ongoing. Mechanistic evidence for liver protection is strong; human outcome data is still limited.

Doses

• 2–4g/day — supported range for homocysteine reduction and strength benefits in healthy adults
• ⚠️ Keep under 4g/day — a meta-analysis found doses ≥4g/day raised total cholesterol and LDL (low-density lipoprotein). Below 4g/day, homocysteine drops without lipid side effects
• 6g/day — used in some RCTs for maximal homocysteine reduction, but LDL risk increases
• klatiWAY protocol: 2–4g/day in the morning shake

Dietary sources

• Wheat germ and bran — richest plant sources (~1% by weight)
• Spinach, beets, quinoa — provide meaningful amounts (~0.5–0.7%)
• Seafood — moderate amounts (~1%)
• Plant-based diets can provide some betaine, but supplementation achieves higher plasma levels than diet alone

Side effects

• Fishy body odor — TMG is metabolized to trimethylamine (TMA), which can cause a fishy smell in sweat and breath. Dose-dependent — more common at higher doses (>4g). Individual gut microbiome composition affects severity
• GI discomfort — nausea, diarrhea at higher doses; generally well-tolerated at 2–4g
• LDL increase — established at ≥4g/day in meta-analysis; keep dose under 4g to avoid this
• TMAO concern — betaine is a confirmed precursor to TMAO (trimethylamine N-oxide, a gut-bacteria-derived cardiovascular risk marker) via gut bacteria metabolism. A landmark 2011 Nature study identified TMAO as a cardiovascular disease risk marker. However, the clinical significance of moderate TMAO increases from supplemental betaine (vs dietary sources) is still debated. This is the most important safety consideration for long-term use
• No serious adverse events reported in clinical trials in healthy adults at doses up to 20g/day

---

Hyaluronic Acid (oral)

Hyaluronic acid (HA) is a large glycosaminoglycan that your body naturally produces. It’s a major component of synovial fluid (joint lubrication), skin (holds water), and the extracellular matrix of connective tissue. Your body’s HA production declines with age — by 50, you have roughly half the HA of a 20-year-old.

The biggest question with oral HA: how does a molecule weighing millions of Daltons get absorbed from the gut? The answer turns out to be: it doesn’t — not intact. Gut microbiota break it down into smaller fragments that are then absorbed and distributed to tissues.

Why hyaluronic acid

• Joint pain reduction — associated with reduced osteoarthritis symptoms, NSAID (non-steroidal anti-inflammatory drug) use, and improved joint function
• Skin hydration — associated with improved skin moisture, elasticity, and barrier function
• Anti-inflammatory — oral HA reduces joint inflammatory markers (IL-1, IL-6, IL-8)
• Safe — excellent tolerability; adverse events in clinical trials are often lower than placebo

What the evidence shows

Joint health — the stronger evidence

A 2024 systematic review of 11 studies (597 patients) found that 9 out of 11 studies showed improvement in osteoarthritis pain and joint function with oral HA. A 2020 RCT using 200mg/day for 8 weeks found significant improvements in pain scores, joint range of motion, and reduced NSAID use compared to placebo.

This is Grade B evidence — multiple RCTs showing consistent direction, but varied formulations and combination products make isolated HA effects hard to pin down.

Skin hydration — consistent but modest

A 2025 systematic review of 7 RCTs found consistent improvements in skin hydration and elasticity. A large 2025 RCT (150 healthy adults) confirmed that oral HA improves skin hydration, barrier function, and signs of aging. A 2014 review also found that oral HA moisturizes dry skin across multiple human trials.

A 2014 animal study using labeled HA showed that dietary hyaluronic acid actually migrates into the skin — providing direct evidence that oral HA reaches its target tissue.

Bioavailability — the mechanism question

A 2023 study using ¹³C-labeled HA demonstrated that gut microbiota are essential for HA absorption. Molecular weight determines uptake patterns — low molecular weight HA (<50 kDa) shows better bioavailability than high molecular weight HA.

This means: HA absorption is real, but it depends on your gut microbiome health and the molecular weight of the product. Full-spectrum formulations (mixed MW) may beat single-MW products.

Honest assessment

Oral HA is not in the same evidence tier as creatine, omega-3, or vitamin D. Those have Grade A evidence with hundreds of RCTs. Oral HA has Grade B evidence — multiple RCTs showing consistent benefits, but with limitations: varied formulations, short follow-up periods, some combination products, and small to moderate sample sizes.

It’s beyond preliminary and supported by multiple independent RCTs — but the effect sizes are modest and the evidence base is smaller than better-studied supplements like creatine or omega-3.

Doses

• 200mg/day — most commonly used dose in RCTs showing joint and skin benefits in adults
• Low molecular weight preferred — studies suggest <50 kDa HA is better absorbed
• klatiWAY protocol: 200mg/day in the morning shake

Side effects

• Generally well-tolerated in healthy adults — adverse events in RCTs are often lower than in placebo groups
• Rare mild GI discomfort — dyspepsia in 2–4% of treatment groups
• No serious adverse events reported across reviewed studies
• Source matters — rooster comb-derived HA may cause allergic reactions in poultry-sensitive individuals; bacterial fermentation-derived HA avoids this
• No known drug interactions in clinical literature

---

Blood Donation

Blood donation 1–2 times per year is included in klatiPRO under lower toxic load. Here’s what the evidence actually supports — and what it doesn’t.

What the evidence supports

Metabolic benefit via iron reduction — Grade A

A randomized controlled trial in 64 metabolic syndrome patients found that phlebotomy (blood removal) significantly reduced:

• Systolic blood pressure: -16.6 mmHg vs control
• Improved glucose, HbA1c, and lipid profiles

This is the strongest evidence — and it’s specific to people with metabolic syndrome and elevated ferritin. The mechanism: excess iron increases oxidative stress and insulin resistance. Removing iron via donation reduces this burden.

Insulin sensitivity — Grade B

A study comparing 181 male blood donors to matched non-donors found that donors had significantly better insulin sensitivity (3.42 vs 2.45) and lower ferritin (101.5 vs 162 μg/L). This is observational — healthy donor bias is possible.

What the evidence does NOT support

Cardiovascular protection — not supported

The largest study (38,244 men, 4-year follow-up) found no cardiovascular benefit from blood donation — relative risk 1.2 (0.8–1.8) for the highest donation frequency group. This directly contradicts the “iron-heart hypothesis” that drove early enthusiasm for blood donation as heart protection.

Cancer risk reduction — mixed

A large case-control study (10,866 cancer cases, 107,140 controls) found a possible reduced risk for iron-associated cancers in men (OR 0.70, 0.58–0.84) — but the authors themselves express doubt due to inconsistency across latency periods. Not reliable enough to recommend donation for cancer prevention.

Longevity — no evidence

No studies found linking regular blood donation to all-cause mortality reduction.

Toxic load removal — no evidence

No evidence that blood donation removes heavy metals, persistent organic pollutants, or other toxins. The “lower toxic load” framing is not supported by published research. The real benefit is iron reduction in people who have too much of it.

Who should donate — and who shouldn’t

Likely to benefit	Should NOT donate regularly
Men with high ferritin (>200 μg/L)	Premenopausal women (already lose iron monthly)
Metabolic syndrome patients	Anyone with ferritin <50 μg/L
Post-menopausal women with high ferritin	Teenagers
Hemochromatosis carriers	Iron-deficient individuals

Recommendation

• Donate 1–2 times per year if ferritin is adequate (check via blood test)
• Main benefit: iron reduction → improved insulin sensitivity and metabolic markers — in people who have excess iron
• Don’t donate as “detox” — that framing is not evidence-based
• Monitor ferritin before and after — the goal is to stay in the optimal range, not to deplete iron

---

check klatiCHECK for klati approved sources

---

Research